306 related articles for article (PubMed ID: 17928466)
21. Enteric-coated mycophenolate sodium.
Gabardi S; Tran JL; Clarkson MR
Ann Pharmacother; 2003 Nov; 37(11):1685-93. PubMed ID: 14565799
[TBL] [Abstract][Full Text] [Related]
22. Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection.
Sanford M; Keating GM
Drugs; 2008; 68(17):2505-33. PubMed ID: 19016576
[TBL] [Abstract][Full Text] [Related]
23. Renal transplant patients with gastrointestinal intolerability to mycophenolate mofetil: conversion to enteric-coated mycophenolate sodium.
Calvo N; Sanchez-Fructuoso AI; Conesa J; Moreno A; Barrientos A
Transplant Proc; 2006 Oct; 38(8):2396-7. PubMed ID: 17097945
[TBL] [Abstract][Full Text] [Related]
24. Safety assessment of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable renal transplant recipients.
Massari P; Duro-Garcia V; Girón F; Hernández E; Juárez F; Castro C; Toledo M;
Transplant Proc; 2005 Mar; 37(2):916-9. PubMed ID: 15848574
[TBL] [Abstract][Full Text] [Related]
25. Quality of life in renal transplant recipients following conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium.
Cofan F; Rosich E; Arias M; Torregrosa V; Oppenheimer F; Campistol JM
Transplant Proc; 2007 Sep; 39(7):2179-81. PubMed ID: 17889130
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
[TBL] [Abstract][Full Text] [Related]
27. Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil.
Lopez-Solis R; DeVera M; Steel J; Fedorek S; Sturdevant M; Hughes C; Humar A
Clin Transplant; 2014 Jul; 28(7):783-8. PubMed ID: 24754682
[TBL] [Abstract][Full Text] [Related]
28. Improvement in Severe Mycophenolic Acid-associated Gastrointestinal Symptoms after Changing Enteric-coated Mycophenolate Sodium to Mizoribine in Renal Transplant Recipients: Two Case Reports.
Liu H; Wang Y; Fan B; Ren L; Wang W; Hu P; Zhang X
Intern Med; 2016; 55(15):2005-10. PubMed ID: 27477406
[TBL] [Abstract][Full Text] [Related]
29. Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolate sodium tablets: Interim results of a multicenter Latin American study.
Abbud-Filho M; Girón F; Hernández E; Juarez F; Liendo C; Novoa P; Toledo M;
Transplant Proc; 2004; 36(6):1647-9. PubMed ID: 15350440
[TBL] [Abstract][Full Text] [Related]
30. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in patients with gastrointestinal side effects: case studies.
Boswell A; Rigg K; Shehata M
Prog Transplant; 2006 Jun; 16(2):138-40. PubMed ID: 16789703
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.
Budde K; Knoll G; Curtis J; Kahana L; Pohanka E; Seifu Y; Neumayer HH
Transplant Proc; 2005 Mar; 37(2):912-5. PubMed ID: 15848573
[TBL] [Abstract][Full Text] [Related]
32. Pre-transplant mycophenolate mofetil pharmacokinetics in Mexican children.
Villa M; González R; García-Roca P; Hernández AM; Ortiz L; Castañeda-Hernández G; Medeiros M
Proc West Pharmacol Soc; 2011; 54():66-8. PubMed ID: 22423584
[TBL] [Abstract][Full Text] [Related]
33. Standard dose enteric-coated mycophenolate sodium (myfortic) delivers rapid therapeutic mycophenolic acid exposure in kidney transplant recipients.
Sumethkul V; Na-Bangchang K; Kantachuvesiri S; Jirasiritham S
Transplant Proc; 2005 Mar; 37(2):861-3. PubMed ID: 15848557
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).
Budde K; Knoll G; Curtis J; Chan L; Pohanka E; Gentil M; Seifu Y; Marrast AC; Neumayer HH;
Clin Nephrol; 2006 Aug; 66(2):103-11. PubMed ID: 16939066
[TBL] [Abstract][Full Text] [Related]
35. Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil.
Behrend M; Braun F
Drugs; 2005; 65(8):1037-50. PubMed ID: 15907141
[TBL] [Abstract][Full Text] [Related]
36. Comparison of enteric-coated mycophenolate sodium with mycophenolate mofetil in living renal allograft transplantation.
Minz M; Sharma A; Heer M
Transplant Proc; 2006 Sep; 38(7):2041-3. PubMed ID: 16979993
[TBL] [Abstract][Full Text] [Related]
37. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study.
Kobashigawa JA; Renlund DG; Gerosa G; Almenar L; Eisen HJ; Keogh AM; Lehmkuhl HB; Livi U; Ross H; Segovia J; Yonan N;
J Heart Lung Transplant; 2006 Aug; 25(8):935-41. PubMed ID: 16890114
[TBL] [Abstract][Full Text] [Related]
38. Enteric-coated mycophenolate-sodium in heart transplantation: efficacy, safety, and pharmacokinetic compared with mycophenolate mofetil.
Lehmkuhl H; Hummel M; Kobashigawa J; Ladenburger S; Rothenburger M; Sack F; Dengler T; Hetzer R
Transplant Proc; 2008 May; 40(4):953-5. PubMed ID: 18555088
[TBL] [Abstract][Full Text] [Related]
39. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients.
de Winter BC; Monchaud C; Prémaud A; Pison C; Kessler R; Reynaud-Gaubert M; Dromer C; Stern M; Guillemain R; Knoop C; Estenne M; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Jan; 51(1):29-39. PubMed ID: 22054177
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of tolerance and safety of conversion from mycophenolate mofetil to enteric-coated mycophenolic acid in renal transplant recipients.
Qiao LW; Qu QS; Jiang X
J Biol Regul Homeost Agents; 2017; 31(1):141-146. PubMed ID: 28337883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
